Abstract:The target samples underwent preprocessing and mass spectrometry imaging to achieve metabolite visualization. Through data analysis, functional visualization was accomplished, potentially leading to the discovery of biomarkers and therapeutic targets for clinical applications, thereby guiding precision medicine. Mass spectrometry imaging (MSI)‐based spatially resolved metabolomics addresses the limitations inherent in traditional liquid chromatography‐tandem mass spectrometry (LC–MS)‐based metabolomics, particularly the loss of spatial context within heterogeneous tissues. MSI not only enhances our understanding of disease aetiology but also aids in the identification of biomarkers and the assessment of drug toxicity and therapeutic efficacy by converting invisible metabolites and biological networks into visually rendered image data. In this comprehensive review, we illuminate the key advancements in MSI‐driven spatially resolved metabolomics over the past few years. We first outline recent innovations in preprocessing methodologies and MSI instrumentation that improve the sensitivity and comprehensiveness of metabolite detection. We then delve into the progress made in functional visualization techniques, which enhance the precision of metabolite identification and annotation. Ultimately, we discuss the significant potential applications of spatially resolved metabolomics technology in translational medicine and drug development, offering new perspectives for future research and clinical translation. Highlights MSI‐driven spatial metabolomics preserves metabolite spatial information, enhancing disease analysis and biomarker discovery. Advances in MSI technology improve detection sensitivity and accuracy, expanding bioanalytical applications. Enhanced visualization techniques refine metabolite identification and spatial distribution analysis. Integration of MSI with AI promises to advance precision medicine and accelerate drug development.

Divide and Conquer: A Flexible Deep Learning Strategy for Exploring Metabolic Heterogeneity from Mass Spectrometry Imaging Data

An end-to-end deep learning method for mass spectrometry data analysis to reveal disease-specific metabolic profiles

Untargeted Pixel-by-Pixel Imaging of Metabolite Ratio Pairs as a Novel Tool for Biomedical Discovery in Mass Spectrometry Imaging

eLIMS: Ensemble Learning-Based Spatial Segmentation of Mass Spectrometry Imaging to Explore Metabolic Heterogeneity

Multi-MSIProcessor: Data Visualizing and Analysis Software for Spatial Metabolomics Research

Seeing is Believing: Developing Multimodal Metabolic Insights at the Molecular Level

Autonomous Multimodal Metabolomics Data Integration for Comprehensive Pathway Analysis and Systems Biology

Molecular network strategy in multi-omics and mass spectrometry imaging

AI-assisted mass spectrometry imaging with in situ image segmentation for subcellular metabolomics analysis

Mass spectrometry imaging methods for visualizing tumor heterogeneity

An integrated deep learning framework for the interpretation of untargeted metabolomics data

TransMetaSegmentation (TMS): a transcriptome-based segmentation method for spatial metabolomic data

Mass Spectrometry for Mitochondrial Multi-Omics

Met4DX: A Unified and Versatile Data Processing Tool for Multidimensional Untargeted Metabolomics Data

Machine Learning-Based Integrated Multiomics Characterization of Colorectal Cancer Reveals Distinctive Metabolic Signatures

Combining MALDI-MS with machine learning for metabolomic characterization of lung cancer patient sera

Toward Mass Spectrometry Imaging in the Metabolomics Scale: Increasing Metabolic Coverage Through Multiple On-Tissue Chemical Modifications

Discriminating Leukemia Cellular Heterogeneity and Screening Metabolite Biomarker Candidates using Label-Free Mass Cytometry

Label-free Mass Cytometry for Unveiling Cellular Metabolic Heterogeneity

Spatially resolved metabolomics: From metabolite mapping to function visualising

Comparing DESI-MSI and MALDI-MSI Mediated Spatial Metabolomics and Their Applications in Cancer Studies